Multiple sclerosis, sporadic Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: Are they autoimmune diseases evoked by Acinetobacter microbes showing molecular mimicry to brain antigens?

Journal of Nutritional and Environmental Medicine

Volumn 14, Issue 4, 2004, Pages 293-302

  Ebringer, A ^a   Rashid, T ^a   Wilson, C ^a   Tiwana, H ^a   Green, A J ^b   Thompson, E J ^b   Chamoun, V ^b   Croker, J R ^c   Binder, A ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c MIDDLESEX HOSPITAL   (United Kingdom)

^d LISTER HOSPITAL   (United Kingdom)

Author keywords

Acinetobacter; Bovine spongiform encephalopathy; Creutzfeldt Jakob disease; Multiple sclerosis

Indexed keywords

BACTERIUM ANTIBODY; BRAIN ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MYELIN BASIC PROTEIN;

ACINETOBACTER; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BOVINE SPONGIFORM ENCEPHALOPATHY; CEREBROVASCULAR ACCIDENT; CHILD; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA; FEMALE; HUMAN; IMMUNE RESPONSE; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEUS; RHEUMATOID ARTHRITIS; VIRUS ENCEPHALITIS;

ACINETOBACTER; BACTERIA (MICROORGANISMS); BOVINAE; ESCHERICHIA; KLEBSIELLA;

EID: 20044372212     PISSN: 13590847     EISSN: None     Source Type: Journal    
DOI: 10.1080/13590840500088131     Document Type: Article

References (34)

1. Gibofsky A, Zabriskie JB. Rheumatic fever. In: Isenberg D, Maddison PJ, Woo P, Glass D, Breedveld FC (eds). Oxford Textbook of Rheumatology. Oxford: Oxford University Press, 2004, 669-77.
2. Wilson C, Ebringer A, Ahmadi K et al. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. Ann Rheum Dis 1995; 54: 216-20.
3. Ebringer A, Rashid T, Wilson C. Rheumatoid arthritis: proposal for the use of anti-microbial therapy in early cases. Scand J Rheumatol 2003; 32: 2-11.
4. Ebringer A, Rahsid T, Wilson C, Ptaszynska T, Fielder M. Ankylosing spondylitis, HLA-B27 and Klebsiella-an overview: proposal for early diagnosis and treatment. Curr Rheumatol Rev (in press).
5. Schwimmbeck PL, Yu DTY, Oldstone MBA. Autoantibodies to HLA-B27 in the sera of HLA-B27 patients with ankylosing spondylitis and Reiter's syndrome: molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 1987; 166: 173-81.
6. Fielder M, Pirt SJ, Tarpey I et al. Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae. FEBS 1995; 369: 243-8.
7. Prusiner SB. Biology and genetics of prion diseases. Ann Rev Microbiol 1994; 48: 655-86.
8. Patterson PY. Experimental allergic encephalomyelitis and autoimmune disease. Adv Immunol 1966; 5: 131-208.
9. Eylar EH, Caccam J, Jackson JJ et al. Experimental allergic encephalomyelitis: synthesis of disease-inducing site of the basic protein. Science 1970; 168: 1220-3.
10. Ebringer A, Pirt SJ, Wilson C et al. Bovine spongiform encephalopathy: is it an autoimmune disease due to bacteria showing molecular mimicry with brain antigens? Environ Health Perspect 1997; 105: 1172-4.
11. Ebringer A, Hughes L, Rashid T, Wilson C. Acinetobacter immune responses in multiple sclerosis: etiopathogenetic role and its possible use as a diagnostic marker. Arch Neurol 2005; 62: 33-6.
12. Tiwana H, Wilson C, Pirt J et al. Autoantibodies to brain components and antibodies to Acinetobacter calcoaceticus are present in bovine spongiform encephalopathy. Infect Immun 1999; 67: 6591-5.
13. Wilson C, Hughes LE, Rashid T et al. Antibodies to Acinetobacter bacteria and bovine brain peptides, measured in bovine spongiform encephalopathy (BSE) in an attempt to develop an antemortem test. J Clin Lab Immunol 2003; 52: 23-40.
14. Hughes LE, Bonell S, Natt RS et al. Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin-Acinetobacter-neurofilament antibody index. Clin Diagn Lab Immunol 2001; 8: 1181-8.
15. Hughes L, Smith PA, Bonell S et al. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. J Neuroimmunol 2003; 144: 105-15.
16. Allerberger F, Berger T, Reindl M et al. Anti-Acinetobacter and anti-neuronal antibodies in Austrian patients with multiple sclerosis and other neurological diseases. Ann Neurol (submitted).
17. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum 1984; 27: 361-7.
18. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
19. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
20. Khalafpour S, Ebringer A, Abuljadayel I et al. Antibodies to Klebsiella and Proteus microorganisms in ankylosing spondylitis and rheumatoid arthritis patients measured by ELISA. Br J Rheumatol 1988; 27(Suppl.II): 86-9.
21. Hafler DA. Multiple sclerosis. J Clin Invest 2004; 113: 788-94.
22. Landtblom AM, Riise T, Boiko A et al. Distribution of multiple sclerosis in Sweden based on mortality and disability compensation statistics. Neuroepidemiology 2002; 21: 167-79.
23. Warren S, Warren KG, Svenson LW et al. Geographic and temporal distribution of mortality rates for multiple sclerosis in Canada, 1965-1994. Neuroepidemiology 2003; 22: 75-81.
24. Cousens SN, Linsell L, Smith PG et al. Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet 1999; 353: 18-21.
25. Rothwell PM, Charlton D. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatr 1998; 64: 730-5.
26. Gilden DH. Viruses and multiple sclerosis. JAMA 2001; 286: 3127-9.
27. Kulkarni AP, Kellaway LA, Lahiri DK et al. Neuroprotection from complement-mediated inflammatory damage. Ann NY Acad Sci 2004; 1035: 147-64.
28. Kovacs GG, Gasque P, Strobel T et al. Complement activation in human prion disease. Neurobiol Dis 2004; 15: 21-8.
29. Ebringer A, Rashid T, Wilson C, Boden R, Thompson E. A possible link between multiple sclerosis and Creutzfeldt-Jakob disease based on clinical, genetic, pathological and immunological evidence involving Acinetobacter bacteria. Med Hypoth 2005; 64: 487-94.
30. Gay D, Dick G, Upton G. Multiple sclerosis associated with sinusitis: case-controlled study in general practice. Lancet 1986; 1: 815-19.
31. Jones RL, Crowe P, Chavda SV et al. The incidence of sinusitis in patients with multiple sclerosis. Rhinology 1997; 35: 118-9.
32. Casiano RR, Cohn S, Villasuso E et al. Comparison of antral tap with endoscopically directed nasal culture. Laryngoscope 2001; 111: 1333-7.
33. Kirvan CA, Swedo SE, Heuser JS et al. Mimicry and autoantibody-mediated neuronal cell signalling in Sydenham chorea. Nat Med 2003; 9: 914-20.
34. Wilson C, Rashid T, Tiwana H et al. Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 2003; 30: 972-8.